(ii) Hemorrhage (severe bleeding).
(iii) Worsening of the condition for which the procedure
is being done.
(iv) Contrast nephropathy (kidney damage due to the
contrast agent used during procedure).
(v) Thrombosis (blood clot forming at or blocking the
blood vessel) at access site or elsewhere including caval thrombosis
(clotting of main vein in abdomen and episodes of swelling of legs).
(vi) Injury to the inferior vena cava (main vein in
abdomen).
(vii) Filter migration or fracture (filter could break
and/or move from where it was placed).
(viii) Risk of recurrent pulmonary embolus (continued
risk of blood clots going to blood vessels in lungs despite filter).
(ix) Inability to remove filter (for "optional"/retrievable
filters).
(I) Pulmonary angiography.
(i) Injury to or occlusion (blocking) of blood vessel
which may require immediate surgery or other intervention.
(ii) Hemorrhage (severe bleeding).
(iii) Damage to parts of the body supplied or drained
by the vessel with resulting loss of use or amputation (removal of
body part).
(iv) Worsening of the condition for which the procedure
is being done.
(v) Contrast nephropathy (kidney damage due to the
contrast agent used during procedure).
(vi) Thrombosis (blood clot forming at or blocking
the blood vessel) at access site or elsewhere.
(vii) Cardiac arrhythmia (irregular heart rhythm) or
cardiac arrest (heart stops beating).
(viii) Cardiac injury/perforation (heart injury).
(ix) Death.
(J) Percutaneous treatment of pseudoaneurysm (percutaneous
thrombin injection through the skin versus compression).
(i) Thrombosis (clotting) of supplying vessel or branches
in its territory.
(ii) Allergic reaction to thrombin (agent used for
direct injection).
(K) Vascular access - nontunneled catheters, tunneled
catheters, implanted access.
(i) Pneumothorax (collapsed lung).
(ii) Injury to blood vessel.
(iii) Hemothorax/hemomediastinum (bleeding into the
chest around the lungs or around the heart).
(iv) Air embolism (passage of air into blood vessel
and possibly to the heart and/or blood vessels entering the lungs).
(v) Vessel thrombosis (clotting of blood vessel).
(L) Varicose vein treatment (percutaneous (through
the skin), via laser, radiofrequency ablation (RFA), chemical or other
method) without angiography.
(i) Burns.
(ii) Deep vein thrombosis (blood clots in deep veins).
(iii) Hyperpigmentation (darkening of skin).
(iv) Skin wound (ulcer).
(v) Telangiectatic matting (appearance of tiny blood
vessels in treated area).
(vi) Paresthesia and dysesthesia (numbness or tingling
in the area or limb treated).
(vii) Injury to blood vessel requiring additional procedure
to treat.
(c) Digestive system treatments and procedures.
(1) Cholecystectomy with or without common bile duct
exploration.
(A) Pancreatitis.
(B) Injury to the tube between the liver and the bowel.
(C) Retained stones in the tube between the liver and
the bowel.
(D) Narrowing or obstruction of the tube between the
liver and the bowel.
(E) Injury to the bowel and/or intestinal obstruction.
(2) Bariatric surgery.
(A) Laparoscopic.
(i) Conversion to open procedure.
(ii) Injury to organs.
(iii) Failure of device requiring additional surgical
procedure.
(iv) Obstructive symptoms requiring additional surgical
procedure.
(v) Development of gallstones (Roux-En-Y).
(vi) Development of metabolic and vitamin disorders
(Roux-En-Y).
(vii) Suture line leak with abscess or fistula formation.
(B) Open.
(i) Failure of wound to heal or wound dehiscence (separation
of wound).
(ii) Injury to organs.
(iii) Failure of device requiring additional surgical
procedure.
(iv) Obstructive symptoms requiring additional surgical
procedure.
(v) Development of gallstones (Roux-En-Y).
(vi) Development of metabolic and vitamin disorders
(Roux-En-Y).
(3) Pancreatectomy (subtotal or total).
(A) Pancreatitis (subtotal).
(B) Diabetes (total).
(C) Lifelong requirement of enzyme and digestive medication.
(D) Anastamotic leaks.
(4) Total colectomy.
(A) Permanent ileostomy.
(B) Injury to organs.
(C) Infection.
(5) Subtotal colectomy.
(A) Anastomotic leaks.
(B) Temporary colostomy.
(C) Infection.
(D) Second surgery.
(E) Injury to organs.
(6) Hepatobiliary drainage/intervention including percutaneous
transhepatic cholangiography, percutaneous biliary drainage, percutaneous
cholecystostomy, biliary stent placement (temporary or permanent),
biliary stone removal/therapy.
(A) Leakage of bile at the skin site or into the abdomen
with possible peritonitis (inflammation of the abdominal lining and
pain or if severe can be life threatening).
(B) Pancreatitis (inflammation of the pancreas).
(C) Hemobilia (bleeding into the bile ducts).
(D) Cholangitis, cholecystitis, sepsis (inflammation/infection
of the bile ducts, gallbladder or blood).
(E) Pneumothorax (collapsed lung) or other pleural
complications (complication involving chest cavity).
(7) Gastrointestinal tract stenting.
(A) Stent migration (stent moves from location in which
it was placed).
(B) Esophageal/bowel perforation (creation of a hole
or tear in the tube from the throat to the stomach or in the intestines).
(C) Tumor ingrowth or other obstruction of stent.
(D) For stent placement in the esophagus (tube from
the throat to the stomach).
(i) Tracheal compression (narrowing of windpipe) with
resulting or worsening of shortness of breath.
(ii) Reflux (stomach contents passing up into esophagus
or higher).
(iii) Aspiration pneumonia (pneumonia from fluid getting
in lungs) (if stent in lower part of the esophagus).
(iv) Foreign body sensation (feeling like there is
something in throat) (for stent placement in the upper esophagus).
(d) Ear treatments and procedures.
(1) Stapedectomy.
(A) Diminished or bad taste.
(B) Total or partial loss of hearing in the operated
ear.
(C) Brief or long-standing dizziness.
(D) Eardrum hole requiring more surgery.
(E) Ringing in the ear.
(2) Reconstruction of auricle of ear for congenital
deformity or trauma.
(A) Less satisfactory appearance compared to possible
alternative artificial ear.
(B) Exposure of implanted material.
(3) Tympanoplasty with mastoidectomy.
(A) Facial nerve paralysis.
(B) Altered or loss of taste.
(C) Recurrence of original disease process.
(D) Total loss of hearing in operated ear.
(E) Dizziness.
(F) Ringing in the ear.
(e) Endocrine system treatments and procedures.
(1) Thyroidectomy.
(A) Acute airway obstruction requiring temporary tracheostomy.
(B) Injury to nerves resulting in hoarseness or impairment
of speech.
(C) Injury to parathyroid glands resulting in low blood
calcium levels that require extensive medication to avoid serious
degenerative conditions, such as cataracts, brittle bones, muscle
weakness and muscle irritability.
(D) Lifelong requirement of thyroid medication.
(2) Parathyroidectomy.
(A) Acute airway obstruction requiring temporary tracheostomy.
Cont'd... |